Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes (Q44673686)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes
scientific article

    Statements

    Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes (English)
    Morton F Goldberg
    Henry Hudson
    D Scott Krueger
    Susan P Luna
    Stella M Robertson
    Stephen Russell
    1 December 2003
    2372-83; discussin 2384-5

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit